2025 annual financial data
Estrella Immunopharma 2025 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -13,062,674 USD and net income was -13,063,512 USD.
Operating cash flow was -1,785,679 USD.
Get free Estrella Immunopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -13,062,674 USD
- Net income
- -13,063,512 USD
- Operating cash flow
- -1,785,679 USD
Explore related company data
View all 2025 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Estrella Immunopharma financial years